Mark A. Kronenfeld Pacira Bio Sciences, Inc. (PCRX) insider trading activity

PCRX Quotes by TradingView

Mark A. Kronenfeld is Director of Pacira BioSciences, Inc.. Currently has a direct ownership of 24,902 shares of PCRX, which is worth approximately $472,639. The most recent transaction as insider was on Jun 12, 2024, when has been sold 5,230 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.9K
0% 3M change
26.59% 12M change
Total Value Held $472,639

Mark A. Kronenfeld Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
5,230 Added 17.36%
24,902 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
1,775 Added 8.28%
19,672 Common Stock
Jun 08 2023
SELL
Open market or private sale
$555,600 $37.04 p/Share
15,000 Reduced 45.6%
17,897 Common Stock
Jun 08 2023
BUY
Exercise of conversion of derivative security
$448,500 $29.9 p/Share
15,000 Added 31.32%
32,897 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
1,160 Added 6.09%
17,897 Common Stock
Jun 09 2021
BUY
Grant, award, or other acquisition
-
1,066 Added 5.99%
16,737 Common Stock
MAK

Mark A. Kronenfeld

Director
Tampa, FL

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCRX